Physician profile
Richard Gordon
NPI 1407859259
$41,036.06
in general payments reported to CMS, 2019-2025
95 companies · $3,800 in 2025
The $3,800 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,629 · 2020: $4,713 · 2021: $7,161 · 2022: $7,330 · 2023: $6,671 · 2024: $5,732 · 2025: $3,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $1,201 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,835.52 |
| Education | $1,201.28 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,246.47 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $2,664.73 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Janssen Biotech, INC. | $2,313.02 | 2019-2025 | Tecvayli, Darzalex, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $1,947.76 | 2019-2025 | Calquence, Enhertu, Lynparza |
| Astellas Pharma US INC | $1,786.82 | 2019-2024 | Padcev, Xtandi, Xospata |
| Incyte Corporation | $1,786.81 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Pharmacyclics LLC, An Abbvie Company | $1,573.52 | 2019-2023 | Imbruvica |
| Pfizer INC. | $1,559.01 | 2019-2025 | |
| Seagen INC. | $1,419.38 | 2019-2023 | Padcev, Adcetris, Tukysa |
| Daiichi Sankyo INC. | $1,350.01 | 2019-2025 | Enhertu, Injectafer, Vanflyta |
| Karyopharm Therapeutics INC. | $1,314.79 | 2020-2025 | Xpovio |
| Glaxosmithkline, LLC. | $1,115.04 | 2020-2022 | |
| Celgene Corporation | $1,046.08 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Lilly USA, LLC | $1,021.62 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Genentech USA, INC. | $1,000.89 | 2019-2025 | Venclexta, Polivy, Lunsumio |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $958.74 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $935.87 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $840.43 | 2019-2025 | |
| Abbvie INC. | $799.17 | 2019-2025 | |
| Amgen INC. | $793.37 | 2019-2023 | Lumakras |
| Bayer Healthcare Pharmaceuticals INC. | $647.74 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $608.22 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Gilead Sciences, INC. | $563.63 | 2019-2025 | Trodelvy |
| Pharmacosmos Therapeutics INC. | $560.55 | 2020-2025 | Monoferric |
| Dova Pharmaceuticals | $426.78 | 2019-2021 | |
| Sobi, INC | $385.42 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $370.09 | 2019-2023 | Tavalisse, Rezlidhia |
| Ipsen Biopharmaceuticals, INC | $357.26 | 2019-2025 | Tazverik, Onivyde, Somatuline Depot |
| Stemline Therapeutics INC. | $309.20 | 2023-2025 | Orserdu |
| Regeneron Healthcare Solutions, INC. | $293.63 | 2022-2025 | Libtayo |
| Jazz Pharmaceuticals INC. | $257.91 | 2019-2022 | |
| Array Biopharma INC | $255.49 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Taiho Oncology, INC. | $253.91 | 2019-2025 | |
| Puma Biotechnology, INC. | $237.66 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $230.17 | 2021-2025 | Fotivda |
| Adaptive Biotechnologies Corporation | $210.10 | 2021-2023 | Clonoseq |
| Acrotech Biopharma INC. | $204.82 | 2021-2023 | Beleodaq |
| Genmab U.S., INC. | $192.48 | 2023-2025 | Tivdak, Epkinly |
| Epizyme, INC. | $183.41 | 2020-2022 | |
| Kite Pharma, INC. | $183.37 | 2020-2025 | Yescarta |
| Emd Serono, INC. | $174.57 | 2019-2025 | Bavencio |
| Geron Corporation | $173.75 | 2025 | Rytelo |
| Servier Pharmaceuticals LLC | $168.03 | 2023-2025 | |
| Adc Therapeutics America, INC. | $166.90 | 2023-2025 | |
| Blueprint Medicines Corporation | $164.64 | 2021-2025 | Ayvakit |
| Teleflex LLC | $159.66 | 2024 | Urolift |
| Aurobindo Pharma USA, INC. | $157.19 | 2019-2020 | |
| Mylan Institutional INC. | $157.16 | 2019-2023 | Ogivri, Fulphila |
| Tersera Therapeutics LLC | $149.31 | 2019-2025 | Zoladex, Xermelo |
| Alexion Pharmaceuticals, INC. | $146.62 | 2021-2025 | Ultomiris |
| Foundation Medicine, INC. | $139.03 | 2019-2023 | Foundationone Cdx, Foundationone Liquid Cdx |
| Secura Bio, INC. | $134.20 | 2019-2021 | |
| Recordati_rare_diseases_inc. | $115.50 | 2023-2025 | Sylvant |
| Coherus Oncology, INC. | $113.99 | 2020-2023 | |
| Exelixis INC. | $105.47 | 2019-2025 | Cabometyx |
| Beigene USA, INC. | $104.59 | 2021-2023 | Brukinsa |
| Morphosys, US INC. | $103.31 | 2021-2023 | Monjuvi |
| Tempus Ai, INC | $103.17 | 2024-2025 | Xt Cdx |
| Apellis Pharmaceuticals, INC. | $98.78 | 2022-2024 | Empaveli |
| Verastem, INC. | $85.50 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $84.75 | 2022 | |
| Heron Therapeutics, INC. | $56.63 | 2019-2023 | Cinvanti |
| Immunocore Limited | $56.55 | 2024-2025 | Kimmtrak |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.05 | 2019-2023 | Gilotrif |
| Acceleron Pharma, INC. | $53.66 | 2020-2021 | |
| Mirati Therapeutics, INC. | $52.54 | 2023-2024 | Krazati |
| Beone Medicines USA, INC. | $50.52 | 2025 | Brukinsa, Tevimbra |
| Organon LLC | $45.63 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $45.34 | 2021-2022 | |
| Deciphera Pharmaceuticals INC. | $44.44 | 2021-2022 | |
| Eusa Pharma (US) LLC | $42.43 | 2021 | |
| Sirtex Medical INC | $38.70 | 2019 | |
| Kyowa Kirin, INC. | $37.59 | 2025 | |
| Legend Biotech USA INC. | $37.35 | 2025 | Carvykti |
| Sumitomo Pharma America, INC. | $32.09 | 2023-2025 | Orgovyx |
| Tesaro, INC. | $29.74 | 2019 | |
| Emmaus Medical, INC. | $28.25 | 2020 | |
| Tg Therapeutics, INC. | $26.75 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.30 | 2019-2021 | |
| Global Blood Therapeutics, INC. | $26.13 | 2020-2021 | |
| Fresenius Kabi USA, LLC | $22.80 | 2023 | Stimufend |
| Agios Pharmaceuticals, INC. | $19.90 | 2025 | Pyrukynd |
| Cti Biopharma Corp. | $18.17 | 2023 | Vonjo |
| Pharmaessentia USA Corporation | $18.11 | 2025 | Besremi |
| Dendreon Pharmaceuticals LLC | $18.10 | 2025 | Provenge |
| Novocure INC. | $17.89 | 2024 | Optune |
| Springworks Therapeutics, INC. | $16.13 | 2025 | Ogsiveo |
| Verity Pharmaceuticals INC. | $16.05 | 2022 | |
| Telix Pharmaceuticals | $14.86 | 2025 | Illuccix |
| Celltrion USA INC. | $14.84 | 2025 | Vegzelma |
| Cumberland Pharmaceuticals, INC. | $14.61 | 2025 | Sancuso |
| Amneal Pharmaceuticals LLC | $14.26 | 2025 | Alymsys |
| Myovant Sciences INC. | $12.51 | 2021 | |
| Innate Pharma, INC | $11.17 | 2020 | |
| Fortovia Therapeutics, INC. | $10.48 | 2019 |
Drugs and devices associated with these payments
Imbruvica $792Tecvayli $770Xpovio $720Darzalex $697Enhertu $602Padcev $520Venclexta $415Keytruda $392Opdivo $374Kisqali $328Monjuvi $313Orserdu $309Reblozyl $306Lenvima $305Trodelvy $298Calquence $270Adcetris $265Stivarga $261Elrexfio $240Lynparza $238Epkinly $234Monoferric $231Ibrance $223Jaypirca $219Verzenio $218Sarclisa $218Jakafi $217Vonjo $201Libtayo $193Tukysa $187Doptelet $185Fotivda $184Rybrevant $178Carvykti $178Rytelo $174Rezlidhia $162Tavalisse $162Urolift $160Injectafer $158Nubeqa $154Scemblix $151Ayvakit $151Vitrakvi $144Ninlaro $131Bosulif $130Pemazyre $127Opdualag $123Sylvant $116Pluvicto $115Pomalyst $113Fabhalta $112Imfinzi $111Tivdak $110Xt Cdx $103Zynlonta $96.75Ultomiris $96.09Braftovi $94.68Mektovi $94.68Welireg $94.58Tazverik $92.13Piqray $91.60Inqovi $89.08Lonsurf $89.08Zoladex $86.10Brukinsa $84.02Erleada $79.05Lorbrena $75.23Xofigo $74.17Inlyta $73.71Tasigna $72.94Retevmo $70.50Krazati $68.61Oxbryta $65.81Empaveli $64.95Jevtana $62.78Kimmtrak $56.55Clonoseq $56.54Xtandi $53.16Fruzaqla $52.33Polivy $51.76Lunsumio $50.76Yescarta $50.68Mekinist $49.36Beleodaq $47.06Vanflyta $45.85Comirnaty $45.69Lumakras $44.17Onivyde $42.07Datroway $37.60Poteligeo $37.59Akeega $37.58Balversa $37.58Talvey $35.68Columvi $33.77Gazyva $33.77Orgovyx $32.09Augtyro $31.66Fulphila $31.53Ogivri $31.53Xospata $31.51
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.